Machine-learning immune-system analysis study may hold clues to personalized medicine
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Mar-2026 18:15 ET (4-Mar-2026 23:15 GMT/UTC)
New research reveals that Covid lockdowns set children's development back by years. The study shows how the pandemic hampered children’s ability to regulate their behaviour, stay focused and adapt to new situations. The greatest impact was seen among pupils who were in reception year (ages four-five) when the first lockdowns began - a crucial stage when youngsters normally learn to socialise, follow routines and navigate the busy world of the classroom.
The team say that children may still be feeling the effects years later.
A UC San Diego study shows that taking a mushroom-derived supplement during COVID-19 vaccination was safe, eased short-term side effects, and supported longer-lasting immune responses, particularly for people receiving their first vaccine.
Scientists have identified molecular and structural changes in taste buds that may explain why a small subset of people experience long-term taste loss after COVID-19 infection.
Researchers at the NUS Yong Loo Lin School of Medicine and Monash University have developed a vaccine booster candidate administered via the nasal route, which confers strong immunity in the respiratory tract. The study offers a promising strategy to enhance immunity and inform future booster approaches.
The COVID-19 pandemic was a major health crisis that challenged citizens’ information management routines. Epistemic ideals guided how people scanned and filtered information, engaged with it and adapted their behaviour accordingly. Conducted in Finland, a recent study found that four distinctive profiles characterise citizens’ engagement with information.
BETHESDA, MD – The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they’re a little disorganized. That’s the surprising finding from researchers who developed a new way to examine these drug-delivery vehicles one particle at a time—revealing that cramming in more medicine doesn't always mean better results. The research will be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026.